W
W. J. van Eden
Researcher at Netherlands Cancer Institute
Publications - 6
Citations - 179
W. J. van Eden is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Oxaliplatin. The author has an hindex of 4, co-authored 6 publications receiving 119 citations.
Papers
More filters
Journal ArticleDOI
Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery
I. van ’t Sant,I. van ’t Sant,W. J. van Eden,M. P. Engbersen,M. P. Engbersen,Nils Kok,K. Woensdregt,Doenja M. J. Lambregts,Doenja M. J. Lambregts,S. Shanmuganathan,Regina G. H. Beets-Tan,Regina G. H. Beets-Tan,Arend G. J. Aalbers,M. J. Lahaye,M. J. Lahaye +14 more
TL;DR: Investigation of whether diffusion‐weighted MRI (DW‐MRI) can be used to select patients for CRS–HIPEC found it to be feasible.
Journal ArticleDOI
Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases
Inge Ubink,W. J. van Eden,Petur Snaebjornsson,Nils Kok,J. van Kuik,W.M.U. Van Grevenstein,M. M. Laclé,Joyce Sanders,Remond J.A. Fijneman,Sjoerd G. Elias,I. H. M. Borel Rinkes,Arend G. J. Aalbers,Onno Kranenburg +12 more
TL;DR: CMS4 status and histopathological features of colorectal peritoneal carcinomatosis were investigated in this study and it was found that CMS4 has the greatest propensity to form distant metastases.
Journal ArticleDOI
Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC
W. J. van Eden,Nils Kok,K. Woensdregt,Alwin D. R. Huitema,Alwin D. R. Huitema,Henk Boot,Arend G. J. Aalbers +6 more
TL;DR: Intraperitoneal oxaliplatin reduced the chemoperfusion time when compared to intraperitoneal MMC without adversely influencing complication rates or short-term survival and may be the preferential drug in CRS-HIPEC procedures for colorectal PC.
Journal ArticleDOI
Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.
W. J. van Eden,Nils Kok,Petur Snaebjornsson,Katarzyna Jóźwiak,K. Woensdregt,P. D. Bottenberg,Henk Boot,Arend G. J. Aalbers +7 more
TL;DR: The aim of this study was to identify prognostic factors for recurrence and survival in Pseudomyxoma peritonei.
Journal ArticleDOI
Effect of intraperitoneal chemotherapy concentration on morbidity and survival.
Fortuné M K Elekonawo,W. J. van Eden,W Y van der Plas,R S G Ewalds,L A W de Jong,A.J.A. Bremers,Patrick H. J. Hemmer,Nils Kok,Schelto Kruijff,Arend G. J. Aalbers,P.R. de Reuver +10 more
TL;DR: The aim of this study was to calculate intraperitoneal chemotherapy concentration during HIPEC and see whether this was related to clinical outcomes.